申请人:Development Center For Biotechnology
公开号:US20150158854A1
公开(公告)日:2015-06-11
A compound for treating a protein kinase-related disease or disorder having a structure of formula (I)
wherein G is a heteroaryl, heterocyclic or alkyne; X is N or CH; L
1
is —N(R
7
)—, —O—, —C(S)—, —C(O)—, or —S—; L
2
is —N(R
8
)— or —O—; R
1
and R
2
are independently hydrogen, halogen, hydroxyl, amino, cyano, nitro, carboxy, C
1
-C
4
alkoxy, C
1
-C
4
alkoxy C
1
-C
4
alkoxy, N,N—(C
1
-C
4
dialkyl)amino C
1
-C
4
alkoxy, N—(C
1
-C
4
alkyl)amino C
1
-C
4
alkoxy, C
1
-C
4
alkanoyl, C
1
-C
4
alkanoyloxy, N—(C
1
-C
4
alkyl)amino, N,N—(C
1
-C
4
dialkyl)amino, C
1
-C
4
alkanoyl amino, or heterocyclyl, wherein C
1
-C
4
alkyl is optionally substituted with one or more substituents selected from fluorine and chlorine; R
3
, R
4
and R
5
are independently hydrogen, fluorine or chlorine; R
6
is C
1
-C
4
alkyl or aryl, which is optionally substituted with one or more substituents selected from halogen, hydroxyl, amino, cyano, nitro; or R
6
and R
8
form a 5-6 membered cyclyl or heterocyclyl.
一种用于治疗蛋白激酶相关疾病或紊乱的化合物,其结构式(I)如下:其中G是杂芳基,杂环基或炔基;X是N或CH;L1是—N(R7)—,—O—,—C(S)—,—C(O)—或—S—;L2是—N(R8)—或—O—;R1和R2分别是氢,卤素,羟基,氨基,氰基,硝基,羧基,C1-C4烷氧基,C1-C4烷氧基C1-C4烷氧基,N,N-(C1-C4二烷基)氨基C1-C4烷氧基,N-(C1-C4烷基)氨基C1-C4烷氧基,C1-C4酰基,C1-C4酰氧基,N-(C1-C4烷基)氨基,N,N-(C1-C4二烷基)氨基,C1-C4酰基氨基或杂环基,其中C1-C4烷基可选地被氟和氯中的一个或多个取代基取代;R3,R4和R5分别是氢,氟或氯;R6是C1-C4烷基或芳基,可选地被一个或多个取代基选自卤素,羟基,氨基,氰基,硝基;或R6和R8形成5-6成员环或杂环基。